Citations

Mayo Clinic

Showing 10 of 108522 citations.

The Correlation between Cardiac Magnetic Resonance Findings and Post-COVID-19: The Impact of Myocardial Injury on Quality of Life
Popović, Maja , Cvetić, Vladimir , Popadić, Višeslav , Ilic, Kristina, Radojevic, Aleksandra , Klasnja, Andrea, Rajović, Nina , Gostiljac, Draško , Klašnja, Slobodan , Mahmutović, Edvin, Zdravković, Marija , Lasica, Ratko , Klasnja, Slobodan , Zdravkovic, Marija , Popadic, Viseslav , Radojevic, Aleksandra , Rajovic, Nina , Cvetic, Vladimir , Milić, Nataša

Diagnostics | September 2, 2024 | Volume: 14 | Issue: 17 | Pages: 1937

10.3390/diagnostics14171937 | PMID 39272722 Get It

Background: In the post-COVID-19 era, there is growing concern regarding its impact on cardiovascular health and the following effects on the overall quality of life of affected individuals. This research seeks to investigate cardiac magnetic resonance (CMR) findings following COVID-19 and their impact on the quality of life of affected individuals. Methods: An observational, cross-sectional study was conducted in consecutive patients with persistent cardiovascular symptoms after COVID-19 who were referred to CMR due to suspected myocardial injury. In addition, patients completed a questionnaire about symptoms and the quality of life during the post-COVID-19 period. Results: In this study, 85 patients were included. The study population consisted of patients with a mean age of 42.5 ± 13.4 years, predominantly women, who made up 69.4% of the study population, while men made up 30.6%. CMR findings showed non-ischemic myocardial injury in 78.8% of patients and myocardial edema in 14.1% of patients. Late pericardial enhancement was present in 40% of patients and pericardial effusion in 51.8% of patients. Pericardial effusion (p = 0.001) was more prevalent in patients who reported more pronounced symptoms in the post-COVID-19 period compared to the acute infection phase. Predictors of lower quality of life in the post-COVID-19 period were the presence of irregular heartbeat (p = 0.039), cardiovascular problems that last longer than 12 weeks (p = 0.018), and the presence of pericardial effusion (p = 0.037). Conclusion: Acute myocarditis was observed in a minority of patients after COVID-19, while non-ischemic LGE pattern and pericardial effusion were observed in the majority. Quality of life was worse during the post-COVID-19 period in patients with CMR abnormalities, primarily in patients with pericardial effusion. Also, irregular heartbeat, cardiovascular symptoms that last longer than 12 weeks, as well as pericardial effusion were independent predictors of lower quality of life during the post-COVID-19 period.
High‐quality FLORET UTE imaging for clinical translation
Willmering, Matthew M. , Krishnamoorthy, Guruprasad , Rosenberg, Jens T. , Woods, Jason C. , Pipe, James G. , Robison, Ryan K.

Magnetic Resonance in Medicine | September 2, 2024 | Volume: 93 | Issue: 1 | Pages: 276-288

10.1002/mrm.30277 | PMID 39219306 Get It

AbstractPurposeTo develop a robust 3D ultrashort‐TE (UTE) protocol that can reproducibly provide high‐quality images, assessed by the ability to yield clinically diagnostic images, and is suitable for clinical translation.Theory and MethodsBuilding on previous work, a UTE sampled with Fermat looped orthogonally encoded trajectories (FLORET) was chosen as a starting point due to its shorter, clinically reasonable scan times. Modifications to previous FLORET implementations included gradient waveform frequency limitations, a new trajectory ordering scheme, a balanced SSFP implementation, fast gradient spoiling, and full inline reconstruction. FLORET images were collected in phantoms and humans on multiple scanners and sites to demonstrate these improvements.ResultsThe updates to FLORET provided high‐quality images in phantom, musculoskeletal, and pulmonary applications. The gradient waveform modifications and new trajectory ordering scheme significantly reduced visible artifacts. Fast spoiling reduced acquisition time by 20%–28%. Across the various scanners and sites, the inline image quality was consistent and of diagnostic quality. Total image acquisition plus reconstruction time was less than 4 min for musculoskeletal and pulmonary applications with reconstructions taking less than 1 min.ConclusionRecently developed improvements for the FLORET sequence have enabled robust, high‐quality UTE acquisitions with short acquisition and reconstruction times. This enables clinical UTE imaging as demonstrated by the implementation of the sequence and acquisition on five MRI scanners, at three different sites, without the need for any additional system characterization or measurements.
Appropriate interpretation of TRBC1 ‐dim positive subsets in T‐cell immunophenotyping by flow cytometry
Weybright, Matthew J. , Otteson, Gregory E., Olteanu, Horatiu , Olteanu, Horatiu , Horna, Pedro , Shi, Min , Jevremović, Dragan

Cytometry Part B: Clinical Cytometry | September 2, 2024 | Volume: 108 | Issue: 2 | Pages: 172-175

10.1002/cyto.b.22204 | PMID 39221577 Get It

Digital Otoscopy With Computer‐Aided Composite Image Generation: Impact on the Correct Diagnosis, Confidence, and Time
Çamalan, Seda , Langefeld, Carl D. , Zinnia, Amy , McKee, Brigham, Carlson, Matthew L. , Deep, Nicholas L. , Harris, Michael S. , Kaul, Vivian F. , Lindquist, Nathan R. , Mattingly, Jameson K. , Shah, Jay , Zhan, Kevin Y. , Harris, Michael S , Jan, Taha Adnan , Gürcan, Metin N. , Moberly, Aaron C.

Otolaryngology–Head and Neck Surgery | September 2, 2024 | Volume: 172 | Issue: 1 | Pages: 152-161

10.1002/ohn.965 | PMID 39221462 Get It

AbstractObjectiveThis study investigated the comparative performance of ear, nose, and throat (ENT) physicians in correctly detecting ear abnormalities when reviewing digital otoscopy imaging using 3 different visualization methods, including computer‐assisted composite images called “SelectStitch,” single video frame “Still” images, and video clips. The study also explored clinicians' diagnostic confidence levels and the time to make a diagnosis.Study DesignClinician diagnostic reader study.SettingOnline diagnostic survey of ENT physicians.MethodsNine ENT physicians reviewed digital otoscopy examinations from 86 ears with various diagnoses (normal, perforation, retraction, middle ear effusion, tympanosclerosis). Otoscopy examinations used artificial‐intelligence (AI)‐based computer‐aided composite image generation from a video clip (SelectStitch), manually selected best still frame from a video clip (Still), or the entire video clip. Statistical analyses included comparisons of ability to detect correct diagnosis, confidence levels, and diagnosis times.ResultsThe ENT physicians' ability to detect ear abnormalities (33.2%‐68.7%) varied depending on the pathologies. SelectStitch and Still images were not statistically different in detecting abnormalities (P > .50), but both were different from Video (P < .01). However, the performance improvement observed with Videos came at the cost of significantly longer time to determining the diagnosis. The level of confidence in the diagnosis was positively associated with correct diagnoses, but varied by particular pathology.ConclusionThis study explores the potential of computer‐assisted techniques like SelectStitch in enhancing otoscopic diagnoses and time‐saving, which could benefit telemedicine settings. Comparable performance between computer‐generated and manually selected images suggests the potential of AI algorithms for otoscopy applications.
The ADNI4 Digital Study: A novel approach to recruitment, screening, and assessment of participants for AD clinical research
Miller, Melanie J. , Diaz, Adam , Conti, Catherine , Albala, Bruce, Flenniken, Derek , Fockler, Juliet , Kwang, Winnie, Sacrey, Diana Truran, Ashford, Miriam T. , Skirrow, Caroline , Weston, Jack , Fristed, Emil , Farias, Sarah Tomaszewski , Korecka, Magda, Wan, Yang , Aisen, Paul, Harvey, Danielle, Petersen, Ronald C. , Okonkwo, Ozioma C. , Weiner, Michael W., Nosheny, Rachel L. , Initiative, Alzheimer's Disease Neuroimaging, Harvey, Danielle , Harvey, Danielle J , Beckett, Laurel , Harvey, Danielle, Lee, Edward B. , Li, Yi‐Ju , Mindt, Mónica Rivera , Initiative, Alzheimer's Disease Neuroimaging

Alzheimer's & Dementia | September 2, 2024 | Volume: 20 | Issue: 10 | Pages: 7232-7247

10.1002/alz.14234 | PMID 39219153 Get It

AbstractINTRODUCTIONWe evaluated preliminary feasibility of a digital, culturally‐informed approach to recruit and screen participants for the Alzheimer's Disease Neuroimaging Initiative (ADNI4).METHODSParticipants were recruited using digital advertising and completed digital surveys (e.g., demographics, medical exclusion criteria, 12‐item Everyday Cognition Scale [ECog‐12]), Novoic Storyteller speech‐based cognitive test). Completion rates and assessment performance were compared between underrepresented populations (URPs: individuals from ethnoculturally minoritized or low education backgrounds) and non‐URPs.RESULTSOf 3099 participants who provided contact information, 654 enrolled in the cohort, and 595 completed at least one assessment. Two hundred forty‐seven participants were from URPs. Of those enrolled, 465 met ADNI4 inclusion criteria and 237 evidenced possible cognitive impairment from ECog‐12 or Storyteller performance. URPs had lower ECog and Storyteller completion rates. Scores varied by ethnocultural group and educational level.DISCUSSIONPreliminary results demonstrate digital recruitment and screening assessment of an older diverse cohort, including those with possible cognitive impairment, are feasible. Improving engagement and achieving educational diversity are key challenges.Highlights A total of 654 participants enrolled in a digital cohort to facilitate ADNI4 recruitment. Culturally‐informed digital ads aided enrollment of underrepresented populations. From those enrolled, 42% were from underrepresented ethnocultural and educational groups. Digital screening tools indicate > 50% of participants likely cognitively impaired. Completion rates and assessment performance vary by ethnocultural group and education.
Pericardial events associated with ibrutinib‐based therapies for chronic lymphocytic leukaemia in two landmark trials
Fakhri, Bita , Wang, Victoria , Perez‐Burbano, Gabriela, Wall, Anna, Mandrekar, Sumithra J. , Parikh, Sameer A. , Woyach, Jennifer A. , Shanafelt, Tait D. , Woyach, Jennifer A , Parikh, Sameer A , Shanafelt, Tait D , Fakhri, Bita

British Journal of Haematology | September 2, 2024 | Volume: 205 | Issue: 4 | Pages: 1645-1648

10.1111/bjh.19710 | PMID 39219152 Get It

Effect of endothelin‐1 on the blood pressure response to acute hypoxia and hyperoxia in healthy young men
Gonsalves, Anna M. , Baker, Sarah , Jacob, Dain W. , Limberg, Jacqueline K. , Limberg, Jacqueline K , Harper, Jennifer L. , Manrique‐Acevedo, Camila

Physiological Reports | September 2, 2024 | Volume: 12 | Issue: 17 | Pages: No page available

10.14814/phy2.70004 | PMID 39218615 Get It

AbstractEndothelin‐1 (ET‐1) and its receptors are linked to increases in sensitivity of the chemoreceptors to hypoxic stress and the development of hypertension in preclinical models. We hypothesized ET receptor antagonism would lower resting blood pressure (BP) as well as the acute BP response to chemoreflex stress. Twenty‐four men (31 ± 5 years, 26 ± 3 kg/m2) completed two study visits (control, bosentan). On each visit, BP was assessed under three conditions: (1) normoxia (FiO2 0.21), (2) chemoreflex excitation via hypoxia (FiO2 0.05–0.21), (3) chemoreflex inhibition via hyperoxia (FiO2 1.00). Bosentan increased plasma ET‐1 (0.94 ± 0.90 to 1.27 ± 0.62 pg/mL, p = 0.004), supporting receptor blockade. Resting diastolic (73 ± 5 to 69 ± 7 mmHg, p = 0.007) and mean (93 ± 7 to 88 ± 7 mmHg, p = 0.005) BP were reduced following bosentan compared to control with no change in systolic BP (p = 0.507). The mean BP response to both acute hypoxia (−0.48 ± 0.38 to −0.25 ± 0.31 mmHg/%, p = 0.004) and hyperoxia (area under the curve −93 ± 108 to −27 ± 66 AU, p = 0.018) were attenuated following bosentan. Acute ET receptor inhibition attenuates the rise in BP during chemoreflex excitation as well as the fall in BP during chemoreflex inhibition in healthy young men. These data support a role for ET‐1 in control of resting BP, possibly through a chemoreceptor‐mediated mechanism.
Bone marrow stromal and anterior cruciate ligament remnant cell co‐culture‐derived extracellular vesicles promote cell activity in both cell types
Wu, Shun Cheng, Liu, Zi‐Miao , Chou, Paul Pei‐Hsi , Zhao, Chunfeng , Lin, Sung-Yen , Ho, Mei‐Ling , Lu, Cheng‐Chang

Journal of Cellular and Molecular Medicine | September 1, 2024 | Volume: 28 | Issue: 17 | Pages: No page available

10.1111/jcmm.70049 | PMID 39219013 Get It

Abstract The significance of anterior cruciate ligament (ACL) remnants during reconstruction remains unclear. Co‐culturing ACL remnant cells and bone marrow stromal cells (BMSCs) may reduce apoptosis and enhance hamstring tendon activity. This study investigated whether extracellular vesicles (EVs), which facilitate cell–cell interactions, act as the active components, improving graft maturation in this co‐culture. The effects of EVs on cell viability, proliferation, migration and gene expression in the rabbit ACL remnant cells and BMSCs were assessed using control (BMSC‐only culture), co‐culture (ACL remnant cells and BMSCs, CM) and co‐culture without EVs (CM ∆ EVs) media. EVs were isolated from control (BMSC‐EV) and co‐culture (CM‐EV) media and characterized. CM significantly enhanced the proliferation, migration and expression of transforming growth factor ( TGF‐β )‐, vascular endothelial growth factor ( VEGF )‐, collagen synthesis‐ and tenogenesis‐related genes. However, CM‐induced effects were reversed by the CM ∆ EVs treatment. CM‐EV treatment exhibited higher potential to enhance proliferation, migration and gene expression in the ACL remnant cells and BMSCs than BMSC‐EV and non‐EV treatments. In conclusion, EVs, secreted under the coexistence of ACL remnant cells and BMSCs, primarily increase the cell viability, proliferation, migration and gene expression of collagen synthesis‐, TGF‐β ‐, VEGF ‐ and tenogenesis‐related genes in both cell types.
A review of sonodynamic therapy for brain tumors
Hutton, Dana , Hossain-Ibrahim, Kismet, Burns, Terry C.

Neurosurgical Focus | September 1, 2024 | Volume: 57 | Issue: 3 | Pages: E7

10.3171/2024.6.focus24338 | PMID 39217635 Get It

OBJECTIVE Sonodynamic therapy (SDT) is gaining attention as a promising new noninvasive brain tumor treatment that targets and selectively kills tumor cells, with limited side effects. This review examines the mechanisms of SDT and ongoing clinical trials looking at optimization of sonication parameters for potential treatment of glioblastoma (GBM) and diffuse intrinsic pontine glioma (DIPG). The results in the first patient with recurrent GBM treated at the Mayo Clinic are briefly discussed. METHODS The authors of this literature review used electronic databases including PubMed, EMBASE, and OVID. Articles reporting relevant preclinical and clinical trials were identified by searching for text words/phrases and MeSH terms, including the following: "sonodynamic therapy," "SDT," "focused ultrasound," "5-ALA," "ALA," "brain tumors," "diffuse pontine glioma," "glioblastoma," and "high grade glioma." RESULTS Preclinical and clinical trials investigating the specific use of SDT in brain tumors were reviewed. In preclinical models of high-grade glioma and GBM, SDT has shown evidence of targeted tumor cell death via the production of reactive oxygen species. Emerging clinical trial results within recurrent GBM and DIPG show evidence of successful treatment response, with minimal side effects experienced by recruited patients. So far, SDT has been shown to be a promising noninvasive cancer treatment that is well tolerated by patients. The authors present pilot data suggesting good radiological response of GBM to a single SDT treatment, with unpublished observation of a lack of off-target effects even after multiple (monthly) sonication outpatient treatments. The scope of the clinical trials of SDT is to investigate whether it can be the means by which the fatal diagnosis of GBM or DIPG is converted into that of a chronic, treatable disease. CONCLUSIONS SDT is safe, repeatable, and better tolerated than both chemotherapy and radiotherapy. It has been shown to have an effect in human cancer therapy, but more clinical trials are needed to establish standardized protocols for sonosensitizer delivery, treatment parameters, and combination therapies. The most appropriate timing of treatment also remains to be determined—whether to prevent recurrence in the postoperative period, or as a salvage option in patients with recurrent GBM for which redo surgery is inappropriate. It is hoped that SDT will also be developed for a wider spectrum of clinical indications, such as metastases, meningioma, and low-grade glioma. Further clinical trials are in preparation.
A Specialist Weighs In: Endocrine and Mental Health
Mouallem, Rayane El, Lteif, Aida, Nofal, Alaa Al , El Mouallem, Rayane, Al Nofal, Alaa

Pediatrics in Review | September 1, 2024 | Volume: 45 | Issue: 9 | Pages: 518-521

10.1542/pir.459commentary | PMID 39217120 Get It